We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
INVO | INVO BioScience Inc | 2.665 | 1.91 | 250.66% | 184,696,984 |
EDBL | Edible Garden AG Inc | 7.6801 | 3.13 | 68.79% | 11,973,598 |
SINT | SiNtx Technologies Inc | 0.0332 | 0.0103 | 44.98% | 388,608,863 |
FCUV | Focus Universal Inc | 0.35 | 0.10 | 40.00% | 3,917,303 |
BCAN | BYND Cannasoft Enterprises Inc | 1.16 | 0.2831 | 32.28% | 6,911,523 |
VNDA | Vanda Pharmaceuticals Inc | 5.30 | 1.25 | 30.86% | 21,258,286 |
TCON | TRACON Pharmaceuticals Inc | 2.22 | 0.51 | 29.82% | 854,017 |
GRTX | Galera Therapeutics Inc | 0.2205 | 0.0505 | 29.71% | 11,166,604 |
VIRX | Viracta Therapeutics Inc | 0.925 | 0.2102 | 29.41% | 179,078 |
CEAD | CEA Industries Inc | 0.6299 | 0.1402 | 28.63% | 135,661 |
SPEC | Spectaire Holdings Inc | 1.02 | 0.2201 | 27.52% | 48,894,906 |
HONG KONG, April 17, 2024 /PRNewswire/ -- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"), announced today that it voluntarily requested a withdrawal of a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (File No.333-275708, the "Registration Statement") and accordingly cancelled the proposed public offering pursuant to the Registration Statement .
WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests and maximize value for all stockholders. The Rights Plan is effective immediately.
WiSA Association, a subsidiary of WiSA Technologies, Inc. (Nasdaq: WISA), announced today that it has executed its fourth 5-year WiSA E licensing agreement with a fourth major HDTV/PTV (Projection TV) brand. The WiSA E license allows the brand to integrate WiSA E software into its products, thereby offering consumers a variety of wireless immersive audio options including full interoperability with any of the WiSA E-enabled speakers offered by the many WiSA Association speaker brands.
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that an independent Data Monitoring Committee (DMC) has recommended continuing the pivotal Phase 3 RAISE trial evaluating intravenous (IV) ganaxolone for the treatment of refractory status epilepticus (RSE) following an interim analysis.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
FNMA | Fannie Mae | 91 | |
AVXL | Anavex Life Sciences Corp | 66 | |
SPZI | SPOOZ Inc | 179 | |
4 | PLPL | Plandai Biotechnology Inc | 88 |
5 | ILST | International Star Inc | 272 |
6 | TPTW | TPT Global Tech Inc | 133 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 61,643.02 | -2,189.72 | -3.43% | 1.2T | 6,869,468,334 |
ETH | Ethereum | 3,025.98 | -59.86 | -1.94% | 360.64B | 2,917,795,828 |
USDT | Tether USD | 0.99992 | -0.00008 | -0.01% | 97.84B | 466,941,796 |
BNB | Binance Coin | 535.93 | -2.21 | -0.41% | 83.87B | 434,953,277 |
SOL | Solana | 134.80 | -1.57 | -1.15% | 58.39B | 2,067,491,803 |
STETH | stETH | 3,013.09 | -51.19 | -1.67% | 29.38B | 15,370,439 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,172,808,437 |
XRP | Ripple | 0.4982 | 0.0014 | 0.28% | 26.79B | 419,963,275 |
DOGE | Dogecoin | 0.15019 | -0.00583 | -3.74% | 21.34B | 626,775,442 |
TONCOIN | Wrapped TON Coin | 6.18 | -0.174961 | -2.75% | 21.34B | 229,816,232 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions